Raphael Mechoulam

Raphael Mechoulam (5 November 1930 – 9 March 2023) was an Israeli organic chemist recognized as a founder of modern cannabinoid research for isolating and determining the structures of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) from Cannabis sativa in the 1960s. His pioneering chemical analyses provided the empirical basis for subsequent pharmacological studies of these compounds, which demonstrated THC's psychoactive properties and CBD's non-intoxicating effects.

Born in Sofia, Bulgaria, to a Jewish family with a physician father, Mechoulam emigrated to Israel in 1949 amid post-World War II upheavals and pursued studies in chemistry at the Hebrew University of Jerusalem, earning an MSc in biochemistry and a PhD in organic chemistry. As a professor at the Hebrew University School of Pharmacy, he extended his investigations into the endogenous regulation of cannabinoid signaling, leading to the 1992 identification of anandamide (N-arachidonoylethanolamine), the first discovered brain constituent that binds to cannabinoid receptors, thus revealing the existence of an endocannabinoid system. Mechoulam's subsequent isolations, including 2-arachidonoylglycerol (2-AG), further mapped this lipid-mediated signaling pathway involved in physiological processes such as pain modulation and appetite regulation.

Raphael Mechoulam was born on November 5, 1930, in Sofia, Bulgaria, into a Sephardic Jewish family. His parents, Moreno and Rosa Mechoulam, were well-educated; his father was an Austrian-born physician who served as the chief of a hospital in Sofia. The family enjoyed relative prosperity before World War II, though Mechoulam later recalled the challenges of growing up amid rising antisemitism and political instability in Bulgaria.

Mechoulam's family, having survived the Holocaust in Bulgaria—where his father had been briefly interned in a concentration camp in 1944—emigrated to Israel in 1949, joining the mass exodus of approximately 45,000 Bulgarian Jews facilitated by communist authorities amid rising antisemitism and economic restrictions. At age 18, Mechoulam arrived in a fledgling state still reeling from the 1948 War of Independence, facing widespread austerity, rationing, and infrastructure shortages that characterized Israel's early years.

Upon immigration, Mechoulam encountered immediate barriers to pursuing chemistry studies at Hebrew University, as the chemical laboratories on Mount Scopus had been destroyed during the war, requiring a year's delay for reconstruction and relocation efforts. Like many young immigrants, he navigated language adaptation—shifting from Bulgarian to Hebrew—and cultural assimilation in a diverse, resource-strapped society, while the family transitioned from relative affluence to modest circumstances amid national priorities for settlement and defense. Mandatory military service further postponed formal education; Mechoulam was drafted into the Israel Defense Forces around 1952-1953, where he gained initial laboratory exposure, though specifics on his role remain limited to general scientific duties rather than specialized research. These hurdles exemplified the broader immigrant experience in 1950s Israel, marked by economic hardship and communal rebuilding, yet they honed Mechoulam's resilience amid a environment prioritizing survival over academic pursuits.